1. Dr Yao (WHO-CI) Dr N’Guessan-Irié (DPM)
PHARMACOVILANCE ACTIVITIES IN CÔTE D’IVOIRE
DELEGATION
Dr Yao (WHO-CI)
Dr N’Guessan-Irié (DPM)

2. PRESENTETION OF THE COUNTRY
Côte d’Ivoire is a french speaking country in west Africa
Area: km2
Population: about 20 millions (1998)
National level of HIV: 4.7% (higher in some areas)
War in 2002
PNPEC = program in charge of people living with HIV
SCMS, PEPFAR, CARE, EGPAF, Clinton Foundation …(ARV products suppliers)

3. INTRODUCTION No National Centre of Pharmacovigilance
Pharmacovigilance supported by DPM (Direction de la Pharmacie et du Médicament)
Project of a Pharmacovigilance Centre creation
Project of Pharmacovigilance of ARVs in PNPEC

4. CURRENT ACTIVITIES of DPM
Reception of reports from AFSSAPS and Pharmaceutical Plants
Diffusion of informations to health practitioners
Information of the Ministry in charge of health for decisions

5. PROJECT FOR THE CENTRE
Identification of products adverse reactions in hospitals, chemist’ shops, program of specific diseases (HIV, TB, leprosy…)
Studies of the different reports at the National Centre
Answers of the Centre to those who notify
Collaboration with international systems (UPSALA, AFSSAPS…)
Form a database for further needs

6. CONCLUSION At present no Pharmacovigilance specific for ARV medicines
The present workshop will contribute to implement pharmacovigilance of ARV medicines in our country

7. THANKYOU FOR PAYING ATTENTION